527 |
New Non-Polymeric Drug Eluting Stent |
Raoul Bonan |
May. 30. 08 |
526 |
Off Label Use of DES |
Augusto D. Pichard |
May. 30. 08 |
525 |
Drug-Eluting Stents Thrombosis: A Real World Experiences from a Single Center |
Runlin Gao |
May. 30. 08 |
524 |
DES Pathology Update - What We Know, What We Do Not Know |
Renu Virmani |
May. 30. 08 |
523 |
Bioabsorbable Polymer Based Paclitaxel Eluting Infinnium Stent for Multivessel Coronary Artery Disease: One Year Follow-Up Results of SIMPLE 3 Registry |
D.S. Gambhir |
May. 30. 08 |
522 |
Long Term Follow Up of DES and Bare Mental Stent in Chinese Single Center Experience |
Fang Chen |
May. 30. 08 |
521 |
Lesson Learned from The First National PCI Registry in Thailand |
Wacin Buddhari |
May. 30. 08 |
520 |
Can Routine IVUS Assessment (and RF Plaque Characterization) Reduce Stent Thrombosis and Restenosis? |
Gary S. Mintz |
May. 30. 08 |
519 |
When and How do I Use DES? Practical Clinical Considerations? Case Selection, Implantation Technique, and Anti-Platelet Therapy |
Antonio Colombo |
May. 30. 08 |
518 |
Do DES Increase or Decrease Mortality for "On-Label" and "Off-Label" Use Indications? |
David R. Holmes |
May. 30. 08 |